Sr. Director, US Alzheimers Diagnostic Strategy and Commercialization

Biogen • Cambridge, MA

121d • $230,000 - $316,000 • Hybrid

About The Position

In this pivotal position at Biogen, as Senior Director of U.S. Diagnostic Strategy and Commercialization, you will spearhead the development and execution of cutting-edge diagnostic strategies for Alzheimer's disease. You will guide the diagnostic approach encompassing blood-based biomarkers, imaging, and cognitive assessment tools, working seamlessly across various teams to ensure diagnostic innovation is seamlessly integrated into our commercial, medical, and access strategies. This role holds significant importance as it directly contributes to improving patient outcomes by enabling timely and accurate detection of Alzheimer's. You will be pivotal in shaping Biogen's diagnostic landscape and ensuring our U.S. Alzheimer's portfolio remains at the forefront of medical advancements.

Requirements

• Advanced degree preferred (PhD, PharmD, MD, or MBA).
• 12+ years of experience in biotech, pharma, or diagnostics, with at least 5 years in neurology, neuroscience, or Alzheimer's disease.
• Strong understanding of the U.S. diagnostic ecosystem, including laboratory operations and reimbursement mechanisms.
• Proven success in leading market-shaping or diagnostic adoption strategies in complex therapeutic areas.
• Strategic thinking and analytical skills, comfortable working with epidemiology and clinical data.
• Excellent collaboration and influencing skills across internal and external stakeholders.
• Entrepreneurial mindset, ability to operate in a fast-paced environment.
• Exceptional communication and executive presence.

Nice To Haves

• Ability to work independently with strong organizational skills.
• Experience leading collaborative initiatives with alliance partners.
• History of successfully managing multiple projects simultaneously.

Responsibilities

• Develop and implement a comprehensive U.S. diagnostic strategy aligned with Alzheimer's disease portfolio goals.
• Identify gaps and opportunities in the diagnostic landscape for Alzheimer's, focusing on innovative tools like blood-based biomarkers and imaging.
• Shape strategies to advance early and precise diagnosis, supporting expanded patient population treatment.
• Collaborate with Market Access and Payer Strategy teams to define coverage and reimbursement pathways for novel diagnostics.
• Work with health economics and outcomes research to establish evidence for diagnostic utility and cost-effectiveness.
• Drive external partnerships with diagnostic companies and labs to promote adoption and guideline inclusion.
• Align diagnostic strategies with biomarker science and clinical trials through collaboration with Medical Affairs.
• Integrate diagnostics into market execution with Marketing, Field Teams, and Alliance partners.
• Partner with Regulatory and Policy teams to navigate diagnostic standards and regulatory requirements.
• Represent Biogen in diagnostic forums and industry consortia to advocate for Alzheimer's detection and diagnosis.
• Build strong relationships with academic centers, diagnostic innovators, and patient advocacy organizations.

Benefits

• Medical, Dental, Vision, & Life insurances.
• Fitness & Wellness programs including a fitness reimbursement.
• Short- and Long-Term Disability insurance.
• A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31).
• Up to 12 company paid holidays + 3 paid days off for Personal Significance.
• 80 hours of sick time per calendar year.
• Paid Maternity and Parental Leave benefit.
• 401(k) program participation with company matched contributions.
• Employee stock purchase plan.
• Tuition reimbursement of up to $10,000 per calendar year.
• Employee Resource Groups participation.

What This Job Offers

• Job Type: Full-time
• Career Level: Director
• Industry: Chemical Manufacturing
• Education Level: Ph.D. or professional degree